Compare Abeona Therapeutics Inc (ABEO) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Utilities Select Sector SPDR Fund — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while Utilities Select Sector SPDR Fund trades at $45.58. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| ABEO | XLU | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | — |
52-Week High | $7.23 | $47.73 |
52-Week Low | $4.17 | $40.57 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
XLU trades at $45.30, down 1.01% today, with a bullish technical signal supported by moving averages. The ETF provides pure exposure to US utilities, benefiting from AI-driven power demand growth. Recent news highlights utilities' role in powering AI data centers, with top holdings securing long-term clean energy agreements. Technical indicators show neutral oscillators but bullish ADX signals, with key support at $44-$45 and resistance at $46.
The outlook for XLU is positive due to structural demand growth from AI infrastructure, though valuation metrics are unavailable. Risks include interest rate sensitivity and regulatory uncertainty. Analyst sentiment is mixed, with utilities transitioning from bond proxies to growth plays amid rising power needs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
